
The Voya Global Advantage and Premium Opportunity Fund, established in the United States on July 7, 2005 (and previously known as the ING Global Advantage and Premium Opportunity Fund), operates as a closed-end equity investment vehicle. It is overseen by Voya Investment Management LLC, with additional management contributions from Voya Investments, LLC, Voya Investment Management Co. LLC, and NNIP Advisors B.V. This fund primarily allocates capital to publicly traded companies across global equity markets, with a focus on value stocks from a wide array of sectors and market capitalizations…
Is IGA's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Voya Investment Management, the asset management business of Voya Financial, Inc. (NYSE: VOYA), announced today the distributions on the common shares of three of its closed-end funds: Voya Global Advantage and Premium Opportunity Fund (NYSE: IGA), Voya Global Equity Dividend and Premium Opportunity Fund (NYSE: IGD), and Voya Infrastructure, Industrials and Materials Fund (NYSE: IDE). With respect to each Fund, the distribution will be paid on November 16, 20.

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Voya Global Advantage and Premium Opportunity Fund (NYSE: IGA), Voya Global Equity Dividend and Premium Opportunity Fund (NYSE: IGD) and Voya Infrastructure, Industrials and Materials Fund (NYSE: IDE) (the “Funds”) today announced important information concerning the Funds' distributions declared in September 2026. This press release is issued as required by the Funds' Managed Distribution Plan (the “Plan") and an exemptive order received from the U.S. Securi.

Voya Global Advantage and Premium Opportunity Fund (NYSE: IGA - Get Free Report) was the recipient of a significant decrease in short interest in the month of September. As of September 30th, there was short interest totaling 27,842 shares, a decrease of 61.2% from the September 15th total of 71,685 shares. Based on an average daily

New Johnson and Johnson ICOTYDEÂ (icotrokinra) long-term data demonstrate robust 2-year results in the treatment of adults and adolescents with plaque psoriasisP

Voya Global Advantage and Premium Opportunity Fund (NYSE: IGA - Get Free Report) was the recipient of a large increase in short interest during the month of September. As of September 15th, there was short interest totaling 71,685 shares, an increase of 53.7% from the August 31st total of 46,630 shares. Based on an average trading